Form 4 holding
HEAD OF TRANSLATIONAL SCIENCE
Addex Therapeutics Ltd.
- Security class
- Common Stock
- Shares / value
- 306,765
- Estimated value
- Report date
- 18 Mar 2026
- Price
- Ownership
- Direct
Mikhail Kalinichev
Insider Reports History
- Reporting-owner location
- Geneva
- Latest reporting-owner signature
-
/s/ Lenaic Nathanael Teyssedou by power of attorney
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Mikhail Kalinichev
Insider Reports Filed by Mikhail Kalinichev
3
ADXN
Addex Therapeutics Ltd.
- Report period
- 18 Mar 2026
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 25 Mar 2026, 16:01
- Role
- HEAD OF TRANSLATIONAL SCIENCE
- Next action
- Open filing details